Kelvin Teo

Dr Kelvin Teo is an Adjunct Associate Lecturer at the Save Sight Institute, part of the Faculty of Medicine and Health at the University of Sydney. His expertise lies in ophthalmology, with a focus on retinal diseases such as age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV). His research integrates advanced imaging technologies like optical coherence tomography (OCT) and OCT angiography to improve diagnostic accuracy and treatment strategies.

Key research interests include understanding disease mechanisms, optimizing anti-VEGF therapies, and exploring novel imaging modalities. Collaborations with global institutions, such as the Asia-Pacific Ocular Imaging Society, highlight his work on PCV diagnostic criteria and treatment paradigms.

Recent publications emphasize the impact of treatment intervals on patient outcomes, racial differences in PCV presentation, and the role of OCT in monitoring choroidal pathology. Despite no explicitly listed awards, his contributions to clinical and epidemiological studies in retinal diseases are significant.

Teo collaborates with multidisciplinary teams and participates in large-scale studies like the Fight Retinal Blindness! Project, contributing to long-term outcome analyses of anti-VEGF therapies. His work bridges basic science and clinical practice, aiming to improve patient care through evidence-based approaches.